Stephen Stout sold $169k of STTK
See Remarks at Shattuck Labs, Inc.. 16,004 shares at an average of $10.53, traded Mar 6, 2024, filed Mar 8, 2024.
Score components
- +15RoleOfficer
- +11Trade size$169k at market
- +5Share of holdings soldSold 19% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-028811, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 6, 2024 | MOption exercise Common Stock10b5-1 | +4,650 | $3.51 | $16k | 83,982 | Mar 8, 2024 |
| Mar 6, 2024 | SOpen-market sale Common Stock10b5-1 | -4,650 | $10.53 | $49k | 79,332 | Mar 8, 2024 |
| Mar 6, 2024 | MOption exercise Common Stock10b5-1 | +6,459 | $3.57 | $23k | 85,791 | Mar 8, 2024 |
| Mar 6, 2024 | SOpen-market sale Common Stock10b5-1 | -6,459 | $10.53 | $68k | 79,332 | Mar 8, 2024 |
| Mar 6, 2024 | SOpen-market sale Common Stock10b5-1 | -4,895 | $10.53 | $52k | 74,437 | Mar 8, 2024 |
| Mar 6, 2024 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -4,650 | $0.00 | $0 | 9,300 | Mar 8, 2024 |
| Mar 6, 2024 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -6,459 | $0.00 | $0 | 17,391 | Mar 8, 2024 |
Related signals
Other insiders at Shattuck Labs, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | Shattuck Labs, Inc. | Abhinav A. Shukla Chief Technical Officer | $2,874 410 shares | -0% | |
| 20Weak | Shattuck Labs, Inc. | Arundathy N. Pandite Chief Medical Officer | $210k 30,000 shares | -18% | |
| 4Weak | Shattuck Labs, Inc. | Abhinav A. Shukla Chief Technical Officer | $166k 23,465 shares | -21% | |
| 42Moderate | STTKbuy Shattuck Labs, Inc. | Clay B Siegall director | $250k 62,500 shares | +24% | |
| 20Weak | Shattuck Labs, Inc. | Arundathy N. Pandite Chief Medical Officer | $198k 30,000 shares | -15% | |
| 0Weak | Shattuck Labs, Inc. | Abhinav A. Shukla Chief Technical Officer | $14k 2,032 shares | -2% | |
| 64Notable | Shattuck Labs, Inc. | Mona Ashiya director | $5.5M 6,306,127 shares | - | |
| 64Notable | Shattuck Labs, Inc. | Orbimed Advisors LLC director | $5.5M 6,306,127 shares | - | |
| 26Weak | STTKbuy Shattuck Labs, Inc. | Redmile Group, LLC director, owner | $167k 133,371 shares | +2% | |
| 26Weak | STTKsell Shattuck Labs, Inc. | Redmile Group, LLC director, owner | $167k 133,371 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.